Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34115103

Efficacy of venetoclax plus rituximab for relapsed CLL: 5-year follow-up of continuous or limited- duration therapy.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2021 Sep 9
First author
Ma S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2021 Sep 9;138(10):819-820. doi: 10.1182/blood.2021012675.
    note
    Source null
    related pmid
    34499155
    relationship
    Comment in

Authors and identifiers

  1. name
    Ma S
    type
    Author
  2. name
    Seymour JF
    type
    Author
  3. name
    Brander DM
    type
    Author
  4. name
    Kipps TJ
    type
    Author
  5. name
    Choi MY
    type
    Author
  6. name
    Anderson MA
    type
    Author
  7. name
    Humphrey K
    type
    Author
  8. name
    Al Masud A
    type
    Author
  9. name
    Pesko J
    type
    Author
  10. name
    Nandam R
    type
    Author
  11. name
    Salem AH
    type
    Author
  12. name
    Chyla B
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Ma S
    type
    Author
  2. name
    Seymour JF
    type
    Author
  3. name
    Brander DM
    type
    Author
  4. name
    Kipps TJ
    type
    Author
  5. name
    Choi MY
    type
    Author
  6. name
    Anderson MA
    type
    Author
  7. name
    Humphrey K
    type
    Author
  8. name
    Al Masud A
    type
    Author
  9. name
    Pesko J
    type
    Author
  10. name
    Nandam R
    type
    Author
  11. name
    Salem AH
    type
    Author
  12. name
    Chyla B
    type
    Author
bibliography ids
  1. nci-bib-4e7c6cd19790d3516ee2e683
book metadata
content sha256
b7511b7923739844b478b7bc928e795941e6a422108556e898c89ba92a8d2c02
document type
citation
dois
  1. 10.1182/blood.2020009578
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:34115103
immutable id
pubmed:34115103@b7511b7923739844b478b7bc928e795941e6a422108556e898c89ba92a8d2c02
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
10
name
Blood
nlm unique id
7603509
pages
836-846
volume
138
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2021 Sep 9;138(10):819-820. doi: 10.1182/blood.2021012675.
    note
    Source null
    related pmid
    34499155
    relationship
    Comment in
outcomes validated
false
pmid
34115103
provenance
batch id
79f1021053e858d13ff3
provider
NCBI PubMed ESummary
record sha256
c00b92607200358a801867b5f4f51e6436ffa628912259f081467322e42a1e54
response sha256
671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
retrieved at
2026-09-09T23:47:59.098265+00:00
publication date
display
2021 Sep 9
precision
day
year
2021
publication types
  1. Clinical Trial
  2. Journal Article
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34115103/
title
Efficacy of venetoclax plus rituximab for relapsed CLL: 5-year follow-up of continuous or limited- duration therapy.

Preserved source evidence · Not medical advice